We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
BioElectronics, a developer of advanced, disposable, therapeutic medical devices,
announced that it has entered into an agreement with PD-Rx for PD-Rx to distribute
ActiPatch Therapy to physicians and healthcare providers that participate in
the PD-Rx programs.
Cyberkinetics Neurotechnology Systems has obtained 510(k) clearances for its
NeuroPort Cortical Microelectrode Array and NeuroPort Neural Signal Processor
(NSP).
SonoSite, a maker of hand-carried ultrasound, announced the results of an independently
conducted survey designed to monitor and track satisfaction levels of its U.S.
customers regarding the SonoSite TITAN, 180PLUS and 180 ELITE product lines.
IVMD, a developer of noninvasive medical diagnostic tests and products, many
of which utilize electromagnetic measurements based on the Hall Effect, a physical
phenomena that measures the electrical activity as it relates to magnetic fields,
announced that it has received second phase funding from Inverness and Nairn
Enterprise, a UK government agency.
MedicalCV announced that it has completed the sale of approximately $13.6 million
of 5 percent Series A convertible preferred stock and common stock purchase
warrants.
Diagnostic Ultrasound DU, a provider of innovative medical devices, announced
the completion of the first phase of a $34 million investment from DW Healthcare
Partners and Rho Private Equity.
Genetronics Biomedical, which is developing oncology and other therapies using
electroporation to deliver drugs and nucleic acids, announced that it has changed
its corporate name to Inovio Biomedical by filing a certificate of amendment
to its certificate of incorporation with the secretary of state of the State
of Delaware.
Dade Behring, a company specializing in hemostasis diagnostics, announced that
their endogenous thrombin potential (ETP) assay for the measurement of thrombin
activity is now available for research studies.